The New York Times @nytimes
Breaking News: An FDA panel recommended approving two vaccines against RSV, a potentially deadly respiratory virus. Those 60 and older would be eligible. https://t.co/l1zhFAM2w0 — PolitiTweet.org
Created
Wed Mar 01 20:26:26 +0000 2023
Likes
230
Retweets
53
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely AvailableThe New York Times @nytimes
Breaking News: An FDA panel recommended approving two vaccines against RSV, a potentially deadly respiratory virus. Those 60 and older would be eligible. https://t.co/l1zhFAM2w0 — PolitiTweet.org